Orthofix Granted PMA for AccelStim Bone Healing Therapy

FDA granted Premarket Approval of Orthofix Medical's AccelStim™ bone healing therapy Class III device. AccelStim provides a nonsurgical treatment for fresh fractures and those that have not healed. The device generates a Low-Intensity Pulsed Ultrasound (LIPUS) signal to stimulate the bone’s natural healing process to promote fracture healing.

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us